Vaccine experts are divided over the Trump administration's Generation Gold Standard project aimed at creating a universal flu vaccine. While some praise the initiative, others question its outdated methods and hefty price tag.
In a shocking move, the FDA has canceled a vital meeting on flu vaccine strains, raising concerns during one of the most severe flu seasons in over a decade. Expert Dr. Paul Offitt weighs in on the implications.
